Institutional Ownership Verve Therapeutics, Inc. (VERV)
This table provides information about the institutional ownership of Verve Therapeutics, Inc. (VERV). We have compiled data on the 186 institutions that hold shares in the stock, with a total of 73.3 Million shares, which have been reported (via 13F filing form) to have a value of $355 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Palo Alto Investors LP
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
575,817
shares
|
$2.62 Million
0.38% of portfolio
|
Q4 2023
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
574,786
shares
|
$2.62 Million
0.0% of portfolio
|
Q3 2024
Added 21.14%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
572,173
shares
|
$2.6 Million
0.0% of portfolio
|
Q3 2024
Added 28.27%
|
|
|
Trexquant Investment LP
Stamford, CT |
Nov 12, 2024 Q3 2024 |
555,502
shares
|
$2.53 Million
0.04% of portfolio
|
Q3 2024
Added 6.13%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
525,000
shares
|
$2.39 Million
0.19% of portfolio
|
Q3 2024
Added 5.0%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
431,769
shares
|
$1.96 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.06%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
430,274
shares
|
$1.96 Million
0.0% of portfolio
|
Q3 2024
Reduced 29.17%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
350,000
shares
|
$1.59 Million
0.12% of portfolio
|
Q4 2022
Reduced 41.67%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
347,029
shares
|
$1.58 Million
0.0% of portfolio
|
Q3 2024
Reduced 6.54%
|
|
|
Los Angeles Capital Management LLC
|
Nov 04, 2024 Q3 2024 |
262,393
shares
|
$1.19 Million
0.01% of portfolio
|
Q3 2024
Added 8.22%
|
|
|
Wade G W & Inc
Wellesley, MA |
Feb 08, 2024 Q4 2023 |
259,626
shares
|
$1.18 Million
0.12% of portfolio
|
Q1 2023
Reduced -0.0%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
226,056
shares
|
$1.03 Million
0.0% of portfolio
|
Q3 2024
Added 25.99%
|
|
|
Algert Global LLC
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
224,216
shares
|
$1.02 Million
0.03% of portfolio
|
Q3 2024
Added 63.07%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
222,919
shares
|
$1.01 Million
0.0% of portfolio
|
Q3 2024
Added 139.76%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
216,901
shares
|
$986,899
0.0% of portfolio
|
Q3 2024
Reduced 14.54%
|
|
|
Rafferty Asset Management, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
210,956
shares
|
$959,849
0.0% of portfolio
|
Q3 2024
Reduced 6.8%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
192,766
shares
|
$877,085
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
184,600
shares
|
$839,930
0.0% of portfolio
|
Q3 2024
Reduced 22.66%
|
|
|
Pdt Partners, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
181,803
shares
|
$827,203
0.09% of portfolio
|
Q3 2024
Reduced 45.55%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
170,000
shares
|
$773,500
0.14% of portfolio
|
Q3 2024
New holding
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
164,127
shares
|
$746,777
0.0% of portfolio
|
Q3 2024
Added 53.82%
|
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Nov 14, 2024 Q3 2024 |
146,100
shares
|
$664,755
0.72% of portfolio
|
Q3 2024
New holding
|
|
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
Aug 15, 2024 Q2 2024 |
132,998
shares
|
$605,140
0.01% of portfolio
|
Q2 2024
Added 825.53%
|
|
|
Stifel Financial Corp
St. Louis, MO |
Nov 14, 2024 Q3 2024 |
131,406
shares
|
$597,897
0.0% of portfolio
|
Q3 2024
Added 14.7%
|
|
|
Hrt Financial LP
New York, NY |
Nov 12, 2024 Q3 2024 |
126,859
shares
|
$577,208
0.0% of portfolio
|
Q3 2024
New holding
|